InspireMD, Inc. (NSPR) stock
Close on Nov 11, 2026Market cap $37.19MP/E –Yield –
InspireMD, Inc. grew revenue 53.4% to $10.84M over the twelve months to Jun 30, 2026. Free cash flow was -$42.46M. At the latest close the market valued the company at $37.19M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $37.19M
- P/E ratio
- –
- Price to sales
- 3.43
- Price to book
- 1.18
- Dividend yield
- –
- Free cash flow yield
- -114.17%
Fundamentals
- Revenue
- $10.84M
- Net income
- -$52.48M
- EPS, diluted
- -$0.76
- Free cash flow
- -$42.46M
- Book value per share
- $0.37
- Diluted shares
- 85M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $0.78
- Open
- $0.79
- Day's range
- $0.73 – $0.82
- Volume
- 247,445
- Average volume (20 days)
- 358,673
- Beta (5 years)
- 0.49
- 52-week range
- $0.43 – $2.22
- RSI (14 days)
- 67.5
- Volatility (1 year)
- 76.2%
- Relative volume
- 1.71×
- WACC
- 7.4%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | NSPR | S&P 500 | Difference | NSPR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +53.6% | -2.4% | +56.0 pts | ||
| 3 months | -6.2% | -1.2% | −5.0 pts | ||
| Year to date | -55.1% | +12.3% | −67.3 pts | ||
| 1 year | -50.9% | +12.4% | −63.4 pts | ||
| 3 years | -74.5% | +78.8% | −153.3 pts | -36.6% | +21.4% |
| 5 years | -80.8% | +75.2% | −155.9 pts | -28.1% | +11.9% |
| 10 years | -100.0% | +311.1% | −411.1 pts | -67.7% | +15.2% |
Fifteen years at a glance
Fiscal years 2008 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases InspireMD filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Update
- Results
- Update
- Update
About InspireMD
Surgical & Medical Instruments & Apparatus
InspireMD is a medical device company that develops and commercializes products for treating carotid artery disease and other vascular conditions. Its core proprietary offering centers on the MicroNet mesh sleeve paired with self-expanding nitinol stents to prevent embolic debris from causing strokes during and after carotid interventions. The company’s commercial portfolio includes the CGuard Carotid Embolic Prevention System, which holds European MDR CE Mark approval, and the CGuard Prime Carotid Stent System, which holds both U.S. FDA premarket approval and MDR CE Mark certification. In addition, the business is developing neuroprotection systems and expanding into transcarotid revascularization and acute stroke therapies. Its customers comprise physicians, healthcare facilities, and patients requiring carotid revascularization.
Company profile, executives and historyInspireMD stock: common questions
What is InspireMD's stock price?
NSPR closed at $0.80 on Nov 11, 2026, up 2.56% on the day. Over the past 52 weeks it traded between $0.43 and $2.22.
What is InspireMD's market cap?
InspireMD was worth $37.19M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is NSPR's P/E ratio?
InspireMD lost money over fiscal 2025 (diluted EPS -$0.76), so it has no meaningful P/E ratio.
How much revenue does InspireMD make?
InspireMD reported revenue of $10.84M for the twelve months to Jun 30, 2026, up 53.4% from a year earlier.
Does InspireMD pay a dividend?
No. InspireMD has not paid a cash dividend over the last twelve months.
When does InspireMD report earnings next?
InspireMD's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has NSPR stock performed over the past year?
Including dividends, NSPR returned -50.9% over the past year, against +12.4% for the S&P 500.
How many NSPR shares are sold short?
0M shares were sold short at the latest FINRA report, 0.79% of the float, or 1.0 days of average trading volume.
Who are InspireMD's competitors?
Companies most similar to InspireMD by business, industry and size include MDNC, XAIR, BDMD, SRTS, EBRCZ.
See a number that looks wrong?